Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Fukuda

Showing results (221-230 of 254) with videos related to

Pageof 26
Sort By:
BMC Cancer|May 3, 2020
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2016
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutationsKosuke Mizoguchi, Yoichi Nakamura, Kazumi Sano, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 28, 2019
Analysis of <i>A4gnt</i> Knockout Mice Reveals an Essential Role for Gastric Sulfomucins in Preventing Gastritis Cystica ProfundaMasatomo Kawakubo, Hitomi Komura, Yukinobu Goso, et al.
The Journal of Experimental Medicine|December 5, 2012
Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cellsAtsushi Nishida, Kiyotaka Nagahama, Hirotsugu Imaeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
HMMC-1: a humanized monoclonal antibody with therapeutic potential against Müllerian duct-related carcinomasShiro Nozawa, Daisuke Aoki, Katsumi Tsukazaki, et al.
Thoracic Cancer|July 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysisShinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, et al.
Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.
British Journal of Haematology|May 11, 2012
De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristicsOlfat Ismael, Akira Shimada, Asahito Hama, et al.
Nature Immunology|March 6, 2007
Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitmentJunya Mitoma, Xingfeng Bao, Bronislawa Petryanik, et al.
Pageof 26

Showing results (221-230 of 254) with videos related to

Sort By:
Pageof 26
BMC Cancer|May 3, 2020
A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK 1603/WJOG 9116L)Kazushige Wakuda, Hiroyuki Yamaguchi, Hirotsugu Kenmotsu, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2016
Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutationsKosuke Mizoguchi, Yoichi Nakamura, Kazumi Sano, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 28, 2019
Analysis of <i>A4gnt</i> Knockout Mice Reveals an Essential Role for Gastric Sulfomucins in Preventing Gastritis Cystica ProfundaMasatomo Kawakubo, Hitomi Komura, Yukinobu Goso, et al.
The Journal of Experimental Medicine|December 5, 2012
Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cellsAtsushi Nishida, Kiyotaka Nagahama, Hirotsugu Imaeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
HMMC-1: a humanized monoclonal antibody with therapeutic potential against Müllerian duct-related carcinomasShiro Nozawa, Daisuke Aoki, Katsumi Tsukazaki, et al.
Thoracic Cancer|July 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysisShinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, et al.
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, et al.
Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.
British Journal of Haematology|May 11, 2012
De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristicsOlfat Ismael, Akira Shimada, Asahito Hama, et al.
Nature Immunology|March 6, 2007
Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitmentJunya Mitoma, Xingfeng Bao, Bronislawa Petryanik, et al.
Pageof 26